Stock listing

NASDAQ:FPRX Five Prime Therapeutics Inc Stock

Follow Five Prime Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:FPRX

$38.00 USD

Close on Apr 16, 2021 · No longer trades

Sep 18, 2013 to last close +190.5% · weekly closes, Sep 18, 2013 – Apr 16, 2021
Lowest – highest close
$1.86 – $60.89 USDSince Sep 18, 2013 · lowest Mar 18, 2020 · highest Nov 25, 2016

Delisted NASDAQ:FPRX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:FPRX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Five Prime Therapeutics Inc on 6ix

Decks
5 decks · latest Jan 15, 2021

Decks

DeckKindSlidesDate
ASCO Gastrointestinal Cancers Symposium 2021Conference15 slidesJan 15, 2021
Technical Presentation (November 2020)Technical14 slidesNov 10, 2020
ASCO 2018Conference15 slidesJun 4, 2018
Corporate Update (November 2017)Corporate update14 slidesNov 8, 2017
Investor Day (December 2016)Investor day77 slidesDec 8, 2016

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Franklin Berger
Other companies: Retension Pharmaceuticals, Inc. (Director · Since at least Oct 13, 2026); Atea Pharmaceuticals, Inc. (Director · Since at least Oct 29, 2020); ESSA Pharma Inc (Director · Since at least Oct 1, 2020); Kezar Life Sciences, Inc. (Director · Since at least Jun 25, 2019); Rain Oncology Inc (Director · Apr 22, 2021 – Jan 26, 2024 · Past); Kineta Inc. (Director · Jun 27, 2019 – Jun 29, 2020 · Past); Atreca Inc (Director · Jun 19, 2019 – Jun 13, 2023 · Past); Tocagen Inc (Director · May 29, 2019 – Oct 4, 2019 · Past); Immune Design Corp (Director · Apr 2, 2019 – Apr 2, 2019 · Past)
Director · Jun 10, 2019 – Apr 16, 2021 · Past
Carol A. Schafer
Other companies: Immunome, Inc. (Director · Since at least Jan 2, 2024); Kura Oncology, Inc. (Director · Since at least Jun 3, 2021); Repare Therapeutics Inc (Director · Since at least May 13, 2021); Insmed Incorporated (Director · Since at least May 12, 2021); Aceragen Inc. (Director · Oct 1, 2020 – Jun 23, 2022 · Past)
Director · Apr 16, 2021 – Apr 16, 2021 · Past
Garry A Nicholson
Other companies: TScan Therapeutics, Inc. (Director · Since at least Jun 12, 2024); Day One Biopharmaceuticals Inc (Director · Since at least Sep 12, 2022); NextCure, Inc. (Director · Jun 24, 2021 – Jun 22, 2023 · Past); G1 Therapeutics Inc (Director · Jun 17, 2021 – Sep 18, 2024 · Past); Turning Point Therapeutics Inc (Director · Jun 2, 2021 – Aug 17, 2022 · Past)
Director · Apr 16, 2021 – Apr 16, 2021 · Past
Helen Collins
Other companies: Enliven Therapeutics, Inc. (Chief Medical Officer · Since at least Feb 23, 2023); Kura Oncology, Inc. (Director · Since at least Jul 28, 2021)
EVP and Chief Medical Officer · Nov 11, 2020 – Mar 31, 2021 · Past
Kevin Paul BakerSVP, Development Sciences · Feb 1, 2016 – Feb 26, 2018 · Past
R Lee DouglasDirector · Sep 17, 2013 – Oct 12, 2016 · Past

Open People

Log in to ask 6ix AI your own questions about Five Prime Therapeutics Inc.